Docusign Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings

Benzinga Earnings
09/04

Docusign Inc (NASDAQ:DOCU) on Thursday posted upbeat financial results for the second quarter of fiscal 2027 and raised its fiscal 2027 revenue outlook.

Docusign posted second-quarter revenue of $875.75 million, beating the consensus estimate of $857.43 million, according to Benzinga Pro. The agreement management company reported adjusted earnings of $1.16 per share for the quarter, beating estimates of $1.09 per share.

Docusign expects third-quarter revenue to be in the range of $886 million to $890 million versus estimates of $888.56 million. The company also raised its fiscal 2027 revenue outlook to $3.499 billion to $3.507 billion, up from $3.49 billion to $3.502 billion, versus estimates of $3.497 billion.

“Docusign is raising its outlook as AI accelerates momentum across the business,” said Allan Thygesen, CEO of Docusign.  “We said IAM would be the agreement system of action, and this quarter we delivered. Our AI agents are now securely executing contract workflows end-to-end, and the IAM platform also ingested a record volume of agreements.”

Docusign shares gained 2.5% to trade at $67.59 on Friday.

These analysts made changes to their price targets on Docusign following earnings announcement.

  • UBS analyst Karl Keirstead maintained the stock with a Neutral and raised the price target from $54 to $70.
  • RBC Capital analyst Rishi Jaluria maintained the stock with a Sector Perform and boosted the price target from $55 to $70.
  • Wells Fargo analyst Michael Turrin maintained the stock with an Equal-Weight rating and raised the price target from $55 to $60.
  • Baird analyst William Power maintained the stock with a Neutral and raised the price target from $55 to $72.
  • B of A Securities analyst Matt Bullock maintained the stock with an Underperform rating and lifted the price target from $58 to $64.

Considering buying DOCU stock? Here’s what analysts think:

Photo via Shutterstock

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10